Analysis of MRSA-attributed costs of hospitalized patients in Germany

摘要: Infections with methicillin-resistant Staphylococcus aureus (MRSA) are assumed to have a high economic impact due increased hygienic measures and prolonged hospital length of stay. However, surveys on the real expenditure for prevention treatment MRSA scarce, in particular regard German Diagnosis-Related Groups (G-DRG) payment system. The aim our study is empirically assess additional cost management identify main drivers whole process from hospital’s point view. We conducted one-year retrospective analysis MRSA-positive cases university determined measures, laboratory costs, opportunity costs isolation time extended lengths A total 182 were included analysis. mean stay was 22.75 days 17.08 days, respectively. Overall, calculated MRSA-attributable € 8,673.04 per case, making up, by far, largest share (77.45 %). Our provides detailed up-to-date MRSA-attributed hospital. It allows current comparison previous studies worldwide. Moreover, it offers prerequisites investigate adequate reimbursement burden DRG system efficiency targeted MRSA.